These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31103265)

  • 41. Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis.
    Sun T; Xu Y; Xu Z; Cao B; Zhang Z; Wang Q; Kong Y; Mao X
    Cell Commun Signal; 2021 Feb; 19(1):24. PubMed ID: 33627137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib.
    Łuczkowska K; Kulig P; Baumert B; Machaliński B
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
    Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
    Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma.
    Yoshida T; Ri M; Kinoshita S; Narita T; Totani H; Ashour R; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
    PLoS One; 2018; 13(5):e0196780. PubMed ID: 29738534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Characteristics and Prognosis of MAF Deletion in Chinese Patients With Multiple Myeloma.
    Wang Y; Li Q; Xing S; Zhang H; Li D
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e545-e550. PubMed ID: 31262667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma.
    Geng YB; Pan CC; Xu C; Zuo PC; Wang Y; Li XO; Zhang LW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9581-9590. PubMed ID: 33015801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lactate Decreases Bortezomib Sensitivity and Predicts Poor Clinical Outcomes of Multiple Myeloma.
    Ma NY; Li Q; Li XL; Zeng YJ; Huang DZ; Duan YS; Xia J; Liu BD; Rao LY; Rao J; Zhang X
    Curr Med Sci; 2023 Aug; 43(4):679-688. PubMed ID: 37326888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
    Zheng JF; Guo NH; Zi FM; Cheng J
    Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138.
    Chen H; Xiao Q; Hu Y; Chen L; Jiang K; Tang Y; Tan Y; Hu W; Wang Z; He J; Liu Y; Cai Y; Yang Q; Ding K
    J Exp Clin Cancer Res; 2017 Jun; 36(1):78. PubMed ID: 28606130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
    Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X
    Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling.
    Tang B; Xu A; Xu J; Huang H; Chen L; Su Y; Zhang L; Li J; Fan F; Deng J; Tang L; Sun C; Hu Y
    Int J Cancer; 2018 Jan; 142(1):109-120. PubMed ID: 28905994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BDNF/TrkB confers bortezomib resistance in multiple myeloma by inducing BRINP3.
    Bao L; Wang Y; Lu M; Shi L; Chu B; Gao S
    Biochim Biophys Acta Gen Subj; 2023 Mar; 1867(3):130299. PubMed ID: 36565997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NCX1/Ca
    Li T; Xiao P; Qiu D; Yang A; Chen Q; Lin J; Liu Y; Chen J; Zeng Z
    Cell Commun Signal; 2024 May; 22(1):258. PubMed ID: 38711131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma.
    Turner JG; Kashyap T; Dawson JL; Gomez J; Bauer AA; Grant S; Dai Y; Shain KH; Meads M; Landesman Y; Sullivan DM
    Oncotarget; 2016 Nov; 7(48):78896-78909. PubMed ID: 27806331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model.
    Kim C; Lee JH; Ko JH; Chinnathambi A; Alharbi SA; Shair OHM; Sethi G; Ahn KS
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31284669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
    Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
    Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone-Targeted Bortezomib Inhibits Bortezomib-Resistant Multiple Myeloma in Mice by Providing Higher Levels of Bortezomib in Bone.
    Tao J; Srinivasan V; Yi X; Zhao Y; Zhang H; Lin X; Zhou X; Boyce BF; Villalta PW; Ebetino FH; Ho KK; Boeckman RK; Xing L
    J Bone Miner Res; 2022 Apr; 37(4):629-642. PubMed ID: 34970782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long noncoding RNA H19 promotes vincristine resistance in multiple myeloma by targeting Akt.
    Wang Y; Xu S; Wang L; Liu J; Wang J; Zhou J
    Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):76-80. PubMed ID: 33040789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.
    Frassanito MA; De Veirman K; Desantis V; Di Marzo L; Vergara D; Ruggieri S; Annese T; Nico B; Menu E; Catacchio I; Ria R; Racanelli V; Maffia M; Angelucci E; Derudas D; Fumarulo R; Dammacco F; Ribatti D; Vanderkerken K; Vacca A
    Leukemia; 2016 Mar; 30(3):640-8. PubMed ID: 26487273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.